Polyplus warburg pincus
WebFeb 24, 2024 · Warburg Pincus’s bid beat out offers from competing buyout firms, the people said. Lyon-based ArchiMed acquired a majority stake in Polyplus in 2016. Polyplus develops delivery solutions for nucleic acids, like DNA and RNA, into cells. The method is used for investigating gene functions, virus production, protein delivery and gene editing. WebApr 29, 2024 · Warburg Pincus’ investment alongside the existing majority shareholder, European private equity healthcare specialist ArchiMed, will advance the development and sale of Polyplus’ breakthrough solutions for the delivery of nucleic acids (transfection) for research and the biologics-based production of therapeutic drugs and vaccines.
Polyplus warburg pincus
Did you know?
WebFeb 10, 2024 · LONDON, February 10, 2024 — Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of … WebApr 5, 2024 · Polyplus was initially acquired by ARCHIMED in 2016, which sold half of its stake to Warburg Pincus in 2024. Polyplus is a global provider of upstream bioprocessing solutions, including transfection reagents and DNA plasmids, which are critical inputs used in the manufacturing of cell and gene therapies.
WebWarburg Pincus LLC is a global private equity firm, headquartered in New York City, with offices in the United States, Europe, ... In April 2024, Warburg Pincus and ArchiMed … WebApr 3, 2024 · 03 April 2024. Kirkland & Ellis is advising co-controlling shareholders WP GG Holdings IV B.V., an affiliate of Warburg Pincus, and ARCHIMED on the sale of Polyplus …
WebApr 29, 2024 · With Warburg Pincus joining us, Polyplus’ competitive advantage will widen further.” ArchiMed invested in Polyplus in 2016 through its inaugural €150 million MED I … WebRuoxi Chen, Managing Director at Warburg Pincus, recently connected with PE Hub Europe to discuss the sale of Polyplus, a leading provider of innovative…
WebSep 20, 2016 · The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B. Join Mergr to view all 292 acquisitions of life science companies in 2016, including 32 acquisitions by private equity firms, and 260 by strategics. Acquired by ArchiMed (Investor) Warburg Pincus (Investor) on 2016-09-20.
small dining room table ideasWebApr 29, 2024 · 29 April 2024. Share. Warburg Pincus has made an investment in Polyplus, a developer of technology used in gene and cell therapy. Warburg’s investment in Polyplus puts the latter at a valuation ... sond medicinWebApr 5, 2024 · Polyplus passe aux mains d’un corporate. Le fournisseur de technologies utilisées dans les thérapies cellulaires et géniques, jusqu’ici détenu par ArchiMed et Warburg Pincus, est en passe d’être racheté par le français Sartorius Stedim Biotech (SSB), fournisseur de matériels pour le secteur biopharmaceutique. sond nylong strapWebRuoxi Chen, Managing Director at Warburg Pincus, recently connected with PE Hub Europe to discuss the sale of Polyplus, a leading provider of innovative… sondok princess of the moon and starsWebPolyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, ... Polyplus-transfection acquired by Warburg Pincus . Acquired by . Warburg Pincus . Announced Date Feb 25, 2024; Price $500M; Frequently Asked Questions. son don\u0027t go near the indians lyricsWebMar 31, 2024 · Strasbourg, France, 31 March 2024 – Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has signed an agreement to … son don\u0027t go near the indians song lyricsWebApr 29, 2024 · Warburg Pincus’ investment alongside the existing majority shareholder, European private equity healthcare specialist ArchiMed, will advance the development and … sond of the forest shovel